|
CEP135 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.180000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.401970E-01 |
| Normal-vs-Stage2 |
4.408400E-01 |
| Normal-vs-Stage3 |
5.035400E-01 |
| Normal-vs-Stage4 |
9.215000E-01 |
| Stage1-vs-Stage2 |
9.375600E-01 |
| Stage1-vs-Stage3 |
5.063800E-01 |
| Stage1-vs-Stage4 |
2.832800E-01 |
| Stage2-vs-Stage3 |
7.355400E-01 |
| Stage2-vs-Stage4 |
5.097000E-01 |
| Stage3-vs-Stage4 |
6.257200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.764850E-01 |
| Normal-vs-AfricanAmerican |
6.497200E-01 |
| Normal-vs-Asian |
6.881800E-02 |
| Caucasian-vs-AfricanAmerican |
1.869580E-01 |
| Caucasian-vs-Asian |
3.627000E-01 |
| AfricanAmerican-vs-Asian |
1.283010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.719200E-01 |
| Normal-vs-Female |
3.739600E-03 |
| Male-vs-Female |
4.153900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.867000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.551700E-02 |
| Normal-vs-Age(61-80Yrs) |
5.841200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.434600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.074600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.528600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.147000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.909900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.146600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.417200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.152600E-04 |
| Normal-vs-Grade 2 |
3.089700E-02 |
| Normal-vs-Grade 3 |
8.980800E-01 |
| Normal-vs-Grade 4 |
8.738800E-01 |
| Grade 1-vs-Grade 2 |
1.560300E-02 |
| Grade 1-vs-Grade 3 |
1.643040E-03 |
| Grade 1-vs-Grade 4 |
1.483330E-03 |
| Grade 2-vs-Grade 3 |
9.140000E-03 |
| Grade 2-vs-Grade 4 |
1.452400E-01 |
| Grade 3-vs-Grade 4 |
7.685000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.241170E-03 |
| Normal-vs-ccB subtype |
6.715200E-01 |
| ccA subtype-vs-ccB subtype |
1.352200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.766500E-02 |
| Normal-vs-N1 |
7.744000E-01 |
| N0-vs-N1 |
3.452800E-01 |
|
|
